CDXC News 1.6000 Chromadex Corp (CDXC)
Post# of 273332
Posted On: 04/16/2014 2:22:00 PM
Chromadex Corp (CDXC) 1.6000 $CDXC
ChromaDex CEO, Frank Jaksch, to Speak at 13th Annual Oxford International Conference on the Science of Botanicals
PR Newswire - Wed Apr 16, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its founder and CEO, Frank Jaksch, will speak at the 13th Annual Oxford International Conference on the Science of Botanicals on April 15th to 17th, 2014.
ChromaDex Signs Material Transfer Agreement With University of Copenhagen for NIAGEN(TM) Nicotinamide Riboside Research
PR Newswire - Tue Apr 15, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with the Novo Nordisk Foundation Center for Basic Metabolic Research at University of Copenhagen, Denmark. ChromaDex will provide the University with quantities of its patented NIAGENTM nicotinamide riboside (NR) ingredient for use in research.
ChromaDex enters into natural product research agreement with Brazilian Research Institute
M2 - Tue Apr 08, 5:03AM CDT
Natural products company ChromaDex (Other OTC:CDXC) stated on Monday that it plans to to evaluate its natural product libraries in a joint collaboration with Brazilian Biosciences National Laboratory (LNBio), part of the Brazilian Center for Research in Energy and Materials (CNPEM), a private research and development institution.
ChromaDex Signs Collaboration Research Agreement with Brazilian Research Institute
PR Newswire - Mon Apr 07, 7:30AM CDT
ChromaDex Corp. (OTCQB:CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a joint collaboration agreement with Brazilian Biosciences National Laboratory (LNBio) to evaluate ChromaDex's natural product libraries.
Thorne Research unveils NiaCel featuring NIAGEN
M2 - Thu Apr 03, 5:47AM CDT
Thorne Research reported on Wednesday the market availability of its innovative nutritional supplement NiaCel, which supports endurance, energy and healthy aging.
Thorne Research Introduces a New Product, NiaCel(TM), Featuring NIAGEN(TM), To Support Healthy Aging
PR Newswire - Wed Apr 02, 7:30AM CDT
Thorne Research today announced the launch of NiaCel(TM), an innovative nutritional supplement that supports endurance, energy, and healthy aging. NiaCel(TM) is one of the first commercially available products to feature the ingredient NIAGEN(TM) from ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic, and pharmaceutical industries.
ChromaDex® Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 5:45AM CDT
ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today the financial results for the year ended December 28, 2013.
ChromaDex Signs Material Transfer Agreement With Leading Dutch University for NIAGEN(TM) Research
PR Newswire - Wed Mar 12, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with the Groningen Biomolecular Sciences & Biotechnology Institute (GBB), a leading research institute at the University of Groningen in the Netherlands. ChromaDex will provide GBB with quantities of its proprietary NIAGEN(TM) nicotinamide riboside (NR) ingredient.
ChromaDex to Present at the 26th Annual ROTH Conference on March 10th at 4:30 pm PDT
PR Newswire - Thu Mar 06, 7:20AM CST
ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the 26th Annual ROTH Conference, which will take place from March 9-12 at the Ritz-Carlton Laguna Niguel in Dana Point, Calif.
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Thu Feb 27, 8:59AM CST
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" television program will feature two emerging growth companies on Fox Business nationwide on Thursday, February 27, 2014 at 10:00 p.m. Pacific (1 a.m. EST). The show will also air on Bloomberg U.K. Saturday, March 1, 2014 at 12:30 a.m. GMT; on Bloomberg Europe Sunday, March 2, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday March 2, 2014 at 3:30 p.m. HKT.
Public Outcry Over Mavuno Church "Gerrit" Poster
by Khikami Obbayi - All Africa Global Media - Wed Feb 26, 12:01AM CST
The Mavuno Church over the weekend put up a controversial poster which has been trending on Social Media as people weigh in on the debate of the appropriateness of the poster's design. The poster which is an advert for a series of sermons to be held during services for the month of March incorporates a picture of would be teens in a presumably intimate position together with titles to secular songs including a controversial book title.
ChromaDex CEO to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference on Wednesday, January 22nd at 8:30 am EST
PR Newswire - Fri Jan 17, 7:30AM CST
ChromaDex Corp.® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida in Room 2 on Wednesday, January 22, 2014 at 8:30 am EST.
ChromaDex CEO Frank Jaksch to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM
Marketwire - Mon Jan 06, 9:12AM CST
ChromaDex(R) Corporation (OTCBB: CDXC) ("ChromaDex" or the "Company", an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today its CEO Frank Jaksch will be interviewed live today by Michal Yorba on Clear Channel Business Talk Radio's The Traders Network. The interview will air on Monday, January 6, 2014, at 2:45pm CST / 12:45pm PST / 3:45pm EST.
ChromaDex® Announces $62 Million Ingredient Agreement with Network Marketing Company 5LINX®
PR Newswire - Mon Jan 06, 7:30AM CST
ChromaDex Corporation® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a four year ingredient supply and brand licensing agreement valued at approximately $62 million, with 5LINX®, one of the largest and fastest-growing direct marketing companies in the world.
ChromaDex® Appoints Former Nestle Executive to Its Board of Directors
PR Newswire - Fri Jan 03, 7:30AM CST
ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company", an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today an addition to its board of directors with the appointment of Steve Allen as an independent director.
International Stevia Council and ChromaDex Enter Into Agreement for Reference Benchmark Standard
PR Newswire - Wed Dec 18, 7:25AM CST
The International Stevia Council (ISC) and ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, have entered into an agreement whereby ChromaDex is to provide, for the next two years, the Reference Benchmark Standard in the ISC's Proficiency Testing Program (PTP) for stevia leaf extracts.
ChromaDex® Updates Research Activity Agreements For Its NIAGEN(TM) Nicotinamide Riboside
PR Newswire - Fri Nov 22, 7:30AM CST
ChromaDex Corporation® (OTCBB: CDXC) ("ChromaDex" or the "Company", an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced an update on recent material transfer agreement activity with significant universities and research institutes for its NIAGEN(TM) nicotinamide riboside (NR).
ChromaDex® Reports Results for the Third Quarter 2013
PR Newswire - Thu Nov 21, 4:50PM CST
ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company", an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the third quarter ended September 28, 2013.
Universite Libre de Bruxelles and ChromaDex® To Collaborate on NIAGEN(TM) Nicotinamide Riboside Research
PR Newswire - Tue Nov 05, 7:20AM CST
ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with Universite Libre de Bruxelles (ULB), whereby ChromaDex will provide ULB with quantities of its recently launched NIAGEN(TM) nicotinamide riboside (NR).
ChromaDex Corp awarded ISO/IEC 17025:2005 certification for quality and excellence in testing practices
M2 - Thu Oct 31, 8:11AM CDT
Natural products company ChromaDex Corp (OTCQB:CDXC) reported on Wednesday the receipt of the internationally recognized ISO (International Organisation for Standardization) and IEC (International Electrotechnical Commission) 17025:2005 accreditation.
ChromaDex CEO, Frank Jaksch, to Speak at 13th Annual Oxford International Conference on the Science of Botanicals
PR Newswire - Wed Apr 16, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its founder and CEO, Frank Jaksch, will speak at the 13th Annual Oxford International Conference on the Science of Botanicals on April 15th to 17th, 2014.
ChromaDex Signs Material Transfer Agreement With University of Copenhagen for NIAGEN(TM) Nicotinamide Riboside Research
PR Newswire - Tue Apr 15, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with the Novo Nordisk Foundation Center for Basic Metabolic Research at University of Copenhagen, Denmark. ChromaDex will provide the University with quantities of its patented NIAGENTM nicotinamide riboside (NR) ingredient for use in research.
ChromaDex enters into natural product research agreement with Brazilian Research Institute
M2 - Tue Apr 08, 5:03AM CDT
Natural products company ChromaDex (Other OTC:CDXC) stated on Monday that it plans to to evaluate its natural product libraries in a joint collaboration with Brazilian Biosciences National Laboratory (LNBio), part of the Brazilian Center for Research in Energy and Materials (CNPEM), a private research and development institution.
ChromaDex Signs Collaboration Research Agreement with Brazilian Research Institute
PR Newswire - Mon Apr 07, 7:30AM CDT
ChromaDex Corp. (OTCQB:CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a joint collaboration agreement with Brazilian Biosciences National Laboratory (LNBio) to evaluate ChromaDex's natural product libraries.
Thorne Research unveils NiaCel featuring NIAGEN
M2 - Thu Apr 03, 5:47AM CDT
Thorne Research reported on Wednesday the market availability of its innovative nutritional supplement NiaCel, which supports endurance, energy and healthy aging.
Thorne Research Introduces a New Product, NiaCel(TM), Featuring NIAGEN(TM), To Support Healthy Aging
PR Newswire - Wed Apr 02, 7:30AM CDT
Thorne Research today announced the launch of NiaCel(TM), an innovative nutritional supplement that supports endurance, energy, and healthy aging. NiaCel(TM) is one of the first commercially available products to feature the ingredient NIAGEN(TM) from ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic, and pharmaceutical industries.
ChromaDex® Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 5:45AM CDT
ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today the financial results for the year ended December 28, 2013.
ChromaDex Signs Material Transfer Agreement With Leading Dutch University for NIAGEN(TM) Research
PR Newswire - Wed Mar 12, 7:25AM CDT
ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with the Groningen Biomolecular Sciences & Biotechnology Institute (GBB), a leading research institute at the University of Groningen in the Netherlands. ChromaDex will provide GBB with quantities of its proprietary NIAGEN(TM) nicotinamide riboside (NR) ingredient.
ChromaDex to Present at the 26th Annual ROTH Conference on March 10th at 4:30 pm PDT
PR Newswire - Thu Mar 06, 7:20AM CST
ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at the 26th Annual ROTH Conference, which will take place from March 9-12 at the Ritz-Carlton Laguna Niguel in Dana Point, Calif.
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Thu Feb 27, 8:59AM CST
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" television program will feature two emerging growth companies on Fox Business nationwide on Thursday, February 27, 2014 at 10:00 p.m. Pacific (1 a.m. EST). The show will also air on Bloomberg U.K. Saturday, March 1, 2014 at 12:30 a.m. GMT; on Bloomberg Europe Sunday, March 2, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday March 2, 2014 at 3:30 p.m. HKT. Public Outcry Over Mavuno Church "Gerrit" Poster
by Khikami Obbayi - All Africa Global Media - Wed Feb 26, 12:01AM CST
The Mavuno Church over the weekend put up a controversial poster which has been trending on Social Media as people weigh in on the debate of the appropriateness of the poster's design. The poster which is an advert for a series of sermons to be held during services for the month of March incorporates a picture of would be teens in a presumably intimate position together with titles to secular songs including a controversial book title.
ChromaDex CEO to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference on Wednesday, January 22nd at 8:30 am EST
PR Newswire - Fri Jan 17, 7:30AM CST
ChromaDex Corp.® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida in Room 2 on Wednesday, January 22, 2014 at 8:30 am EST.
ChromaDex CEO Frank Jaksch to Be Interviewed Today on Clear Channel Business Talk Radio DFW 1190AM
Marketwire - Mon Jan 06, 9:12AM CST
ChromaDex(R) Corporation (OTCBB: CDXC) ("ChromaDex" or the "Company"
, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today its CEO Frank Jaksch will be interviewed live today by Michal Yorba on Clear Channel Business Talk Radio's The Traders Network. The interview will air on Monday, January 6, 2014, at 2:45pm CST / 12:45pm PST / 3:45pm EST. ChromaDex® Announces $62 Million Ingredient Agreement with Network Marketing Company 5LINX®
PR Newswire - Mon Jan 06, 7:30AM CST
ChromaDex Corporation® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a four year ingredient supply and brand licensing agreement valued at approximately $62 million, with 5LINX®, one of the largest and fastest-growing direct marketing companies in the world.
ChromaDex® Appoints Former Nestle Executive to Its Board of Directors
PR Newswire - Fri Jan 03, 7:30AM CST
ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"
, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today an addition to its board of directors with the appointment of Steve Allen as an independent director. International Stevia Council and ChromaDex Enter Into Agreement for Reference Benchmark Standard
PR Newswire - Wed Dec 18, 7:25AM CST
The International Stevia Council (ISC) and ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, have entered into an agreement whereby ChromaDex is to provide, for the next two years, the Reference Benchmark Standard in the ISC's Proficiency Testing Program (PTP) for stevia leaf extracts.
ChromaDex® Updates Research Activity Agreements For Its NIAGEN(TM) Nicotinamide Riboside
PR Newswire - Fri Nov 22, 7:30AM CST
ChromaDex Corporation® (OTCBB: CDXC) ("ChromaDex" or the "Company"
, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced an update on recent material transfer agreement activity with significant universities and research institutes for its NIAGEN(TM) nicotinamide riboside (NR). ChromaDex® Reports Results for the Third Quarter 2013
PR Newswire - Thu Nov 21, 4:50PM CST
ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"
, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today financial results for the third quarter ended September 28, 2013. Universite Libre de Bruxelles and ChromaDex® To Collaborate on NIAGEN(TM) Nicotinamide Riboside Research
PR Newswire - Tue Nov 05, 7:20AM CST
ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with Universite Libre de Bruxelles (ULB), whereby ChromaDex will provide ULB with quantities of its recently launched NIAGEN(TM) nicotinamide riboside (NR).
ChromaDex Corp awarded ISO/IEC 17025:2005 certification for quality and excellence in testing practices
M2 - Thu Oct 31, 8:11AM CDT
Natural products company ChromaDex Corp (OTCQB:CDXC) reported on Wednesday the receipt of the internationally recognized ISO (International Organisation for Standardization) and IEC (International Electrotechnical Commission) 17025:2005 accreditation.
(0)
(0)